Skip to content

Clinical trials

Completed Brain Diseases trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Brain Diseases Status: Completed Country / region: Germany Clear all

30 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20101
20114
20123
20132
20141
20151
20164
20172
20192
20205
20212
20221
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed30

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie4
University of Rostock4
Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc.3
TauRx Therapeutics Ltd2
Aesculap AG1
Alkahest, Inc.1
Avraham Pharmaceuticals Ltd1
CENTOGENE GmbH Rostock1
Charite University, Berlin, Germany1
Eli Lilly and Company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Brain Diseases30
Central Nervous System Diseases17
Nervous System Diseases15
Neurodegenerative Diseases11
Movement Disorders7
Dementia6
Parkinson Disease6
Cerebrovascular Disorders5
Mental Disorders5
Parkinsonian Disorders5

Trials

Showing 1 to 25 of 30. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.